CERVOMED ANNOUNCES NEW CLINICAL, PLASMA BIOMARKER AND IMAGING DATA AT AAIC 2026 FOR NEFLAMAPIMOD IN THE TREATMENT OF DEMENTIA WITH LEWY BODIES (DLB)

Reuters · 1d ago

Please log in to view news